The effects of apigenin on A2058 and A375 melanoma cells have been evaluated [57], consistent with our studies, apigenin effectively inhibited the cell migration of HeLa and C33A cells via inactivation of the FAK signaling (FAK, paxillin, and integrin β1) pathways. This evidence concerns the gene PXN and melanoma.